comparemela.com

Latest Breaking News On - Taiwan patent - Page 1 : comparemela.com

ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)

The Company Holds a US Patent for the Same TreatmentFREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) viaNewMediaWire ABVC BioPharma, Inc. (NASD.

United statesStanford universityUttam patilTom mastersonTrademark officeBiopharma incUniversity of california at san franciscoSinai medical centerEuropean unionCompany annual report on formExchange commissionCompany holdsRadix polygalaMajor depressive disorderTaiwan patentMajor depressive

ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD) - ABVC BioPharma (NASDAQ:ABVC)

The Company Holds a US Patent for the Same Treatment FREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) via NewMediaWire ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical

United statesStanford universityTom mastersonUttam patilUniversity of california at san franciscoEuropean unionSinai medical centerExchange commissionBiopharma incCompany annual report on formTrademark officeCompany holdsRadix polygalaMajor depressive disorderTaiwan patentMajor depressive

ABVC BioPharma Gets Taiwanese Patent For Use Of Polygala Extract For Depressive Disorder

(RTTNews) - Biopharmaceutical company ABVC BioPharma, Inc. (ABVC) announced Monday that it received a Taiwanese patent, Application No. 109130285,.

Trademark officeBiopharma incRadix polygalaMajor depressive disorderTaiwan patentMajor depressiveNorepinephrine transporter

Semiconductor supplier claims infringement

Bringing Taiwan to the World and the World to Taiwan

T ai peiSu fu nanSamsung electronics coIntel corpTaipei timesMinistry of economic affairsEntegris incTaiwan semiconductor manufacturing coGudeng precision industrial coLisa wangTaiwan patentIntellectual propertyCommercial courtEconomic affairsNew taipei city tucheng districtThe taipei times

Viveve Medical, Inc : Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan

ENGLEWOOD, CO / ACCESSWIRE / July 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced

United statesScott durbinBill berryDrug administrationViveve incTaiwan intellectual property officeViveve medical incBerry company public relationsSecurities exchangeDynamic medical technologies incViveve medicalTaiwan patentMedical technologiesCryogen cooled monopolar radiofrequencyInvestigational device exemptionSecurities act

vimarsana © 2020. All Rights Reserved.